CoLucid Pharmaceuticals, Inc. 4
4 · CoLucid Pharmaceuticals, Inc. · Filed Sep 16, 2016
Insider Transaction Report
Form 4
Mathers Thomas P.
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2016-09-14$23.30/sh−5,700$132,812→ 244,714 total - Sale
Common Stock
2016-09-14$23.78/sh−300$7,134→ 244,414 total
Footnotes (3)
- [F1]Securities sold pursuant to a written plan intended to comply with Rule 10b5-1(c)(i) adopted by Mr. Mathers on August 19, 2016.
- [F2]Represents the sale of 5,700 shares in multiple transactions, ranging in price from $22.73 to $23.72 per share, resulting in a weighted average sale price of $23.3004. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
- [F3]Represents the sale of 300 shares in multiple transactions, ranging in price from $23.77 to $23.79 per share, resulting in a weighted average sale price of $23.78. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.